The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells

Molecular Biology of the Cell

Volumn 18, Issue 5, 2007, Pages 1768-1780

  Cardone, Rosa A ^a   Bellizzi, Antonia ^a,b   Busco, Giovanni ^a   Weinman, Edward J ^c,d   Dell'Aquila, Maria E ^a   Casavola, Valeria ^a   Azzariti, Amalia ^b   Mangia, Anita ^b   Paradiso, Angelo ^b   Reshkin, Stephan J ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MATRIGEL; PDZ 2 PROTEIN; PDZ PROTEIN; RHO A PROTEIN; RHO FACTOR; SODIUM PROTON EXCHANGE PROTEIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST BIOPSY; BREAST TUMOR; CELL ACTIVATION; CELL CULTURE; CELL INVASION; CLINICAL ARTICLE; DISEASE COURSE; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; METASTASIS; MICROENVIRONMENT; MORPHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSEUDOPODIUM; REGULATORY MECHANISM; TUMOR BIOPSY; TUMOR CELL;

ANOXIA; BREAST NEOPLASMS; CATION TRANSPORT PROTEINS; CELL LINE, TUMOR; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PROGNOSIS; PROTEIN STRUCTURE, TERTIARY; PSEUDOPODIA; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER;

EID: 34248216496     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E06-07-0617     Document Type: Article

References (61)

1. Axelson, H., Fredlund, E., Ovenberger, M., Landberg, G., and Pahlman, S. (2005). Hypoxia-induced dedifferentiation of tumor cells-a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin. Cell Dev. Biol. 16, 554-563.
2. Brone, B., and Eggermont, J. (2005). PDZ proteins retain and regulate membrane transporters in polarized epithelial cell membranes. Am. J. Physiol. 288, C20-C29.
3. Burack, W. R., and Shaw, A. S. (2000). Signal transduction: hanging on a scaffold. Curr. Opin. Cell Biol. 12, 211-216.
4. Busca, R., Bertolotto, C., Abbe, P., Englaro, W., Ishizaki, T., Narumiya, S., Boquet, P., Ortonne, J. P., and Ballotti, R. (1998). Inhibition of Rho is required for cAMP-induced melanoma cell differentiation. Mol. Biol. Cell 9, 1367-1378.
5. Cardone, R. A., Bagorda, A., Bellizzi, A., Busco, G., Guerra, L., Paradiso, A., Casavola, V., Zaccolo, M., and Reshkin, S. J. (2005a). Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines. Mol. Biol. Cell 16, 3117-3127.
6. Cardone, R. A., Casavola, V., and Reshkin, S. J. (2005b). The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat. Rev. Cancer 5, 786-795.
7. Christofori, G. (2006). New signals from the invasive front. Nature 441, 444-450.
8. Covello, K. L., and Simon, M. C. (2004). HIFs, hypoxia, and vascular development. Curr. Top. Dev. Biol. 62, 37-54.
9. Dai, J. L., Wang, L., Sahin, A. A., Broemeling, L. D., Schutte, M., and Pan, Y. (2004). NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer. Oncogene 23, 8681-8687.
10. Debnath, J., and Brugge, J. S. (2005). Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 5, 675-688.
11. Denker, S. P., Huang, D. C, Orlowski, J., Furthmayr, H., and Barber, D. L. (2000). Direct binding of the Na-H exchanger NHE1 to ERM proteins regulates the cortical cytoskeleton and cell shape independently of H(+) translocation. Mol. Cell 6, 1425-1436.
12. De Wever, O., Nguyen, Q. D., Van Hoorde, L., Bracke, M., Bruyneel, E., Gespach, C., and Mareel, M. (2004). Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J. 18, 1016-1018.
13. Duffy, M. J. (2005). Predictive markers in breast and other cancers: a review. Clin. Chem. 51, 494-503.
14. Ediger, T. R., Kraus, W. L., Weinman, E. J., and Katzenellenbogen, B. S. (1999). Estrogen receptor regulation of the Na+/H+ exchange regulatory factor. Endocrinology 140, 2976-2982.
15. Elston, C. W., and Ellis, I. O. (2002). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991; 19, 403-410.
16. Histopathology 41, 151.
17. Fraenzer, J. T., Pan, H., Minimo, L., Jr., Smith, G. M., Knauer, D., and Hung, G. (2003). Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation. Int. J. Oncol. 23, 1493-1500.
18. Friedl, P., Hegerfeldt, Y., and Tusch, M. (2004). Collective cell migration in morphogenesis and cancer. Int. J. Dev. Biol. 48, 441-449.
19. Gatto, C. L., Walker, B. J., and Lambert, S. (2003). Local ERM activation and dynamic growth cones at Schwann cell tips implicated in efficient formation of nodes of Ranvier. J. Cell Biol. 162, 489-498.
20. Gillies, R. J., Raghunand, N., Karczmar, G. S., and Bhujwalla, Z. M. (2002). MRI of the tumor microenvironment. J. Magn. Reson. Imaging 16, 430-450.
21. Greene, F. L., and Sobin, L. H. (2002). The TNM system: our language for cancer care. J. Surg. Oncol. 80, 119-120.
22. Harguindey, S., Orive, G., Luis Pedraz, J., Paradiso, A., and Reshkin, S. J. (2005). The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature. Biochim. Biophys. Acta 1756, 1-24.
23. Hopfl, G., Ogunshola, O., and Gassmann, M. (2004). HIFs and tumors-causes and consequences. Am. J. Physiol. 286, R608-R623.
24. Hunter, K. W. (2004). Ezrin, a key component in tumor metastasis. Trends Mol. Med. 10, 201-204.
25. Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., and Thun, M. J. (2005). Cancer statistics, 2005. CA Cancer J. Clin. 55, 10-30.
26. Jia, Z., Vadnais, J., Lu, M. L., Noel, J., and Nabi, I. R. (2006). Rho/ROCK-dependent pseudopodial protrusion and cellular blebbing are regulated by p38 MAPK in tumour cells exhibiting autocrine c-Met activation. Biol. Cell 98, 337-351.
27. Kishida, S., Yamamoto, H., and Kikuchi, A. (2004). Wnt-3a and Dvl induce neurite retraction by activating Rho-associated kinase. Mol. Cell Biol. 24, 4487-4501.
28. Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F., Feldser, D., Ferreira, G., Iyer, N., LaRusch, J., Pak, B., Taghavi, P., and Semenza, G. L. (2003). Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63, 1138-1143.
29. Lefsky, J. M. (2001). Nuclear receptor minireview series. J. Biol. Chem. 276, 36863-36864.
30. Li, Q., Lau, A., Morris, T. J., Guo, L., Fordyce, C. B., and Stanley, E. F. (2004). A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J. Neurosci. 24, 4070-4081.
31. Luo, L. (2000). Rho GTPases in neuronal morphogenesis. Nat. Rev. Neurosci. 1, 173-180.
32. Mareel, M., and Leroy, A. (2003). Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 83, 337-376.
33. McHardy, L. M., Sinotte, R., Troussard, A., Sheldon, C., Church, J., Williams, D. E., Andersen, R. J., Dedhar, S., Roberge, M., and Roskelley, C. D. (2004). The tumor invasion inhibitor dihydromotuporamine C activates RHO, remodels stress fibers and focal adhesions, and stimulates sodium-proton exchange. Cancer Res. 64, 1468-1474.
34. Mery, L., Strauss, B., Dufour, J. F., Krause, K. H., and Hoth, M. (2002). The PDZ-interacting domain of TRPC4 controls its localization and surface expression in HEK293 cells. J. Cell Sci. 115, 3497-3508.
35. Moyano, J. V. et al. (2006). AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J. Clin. Investig. 116, 261-270.
36. Nourry, C., Grant, S. G., and Borg, J. P. (2003). PDZ domain proteins: plug and play! Sci. STKE 2003, RE7.
37. Offersen, B. V., Sørensen, F. B., and Knoop, J. (2003). The prognostic relevance of estimates of proliferative activity in early breast cancer. Overgaard. Histopathol. 43, 573.
38. Pan, Y., Oprysko, P. R., Asham, A. M., Koch, C. J., and Simon, M. C. (2004). p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment. Oncogene 23, 4975-4983.
39. Paradiso, A., Cardone, R. A., Bellizzi, A., Bagorda, A., Guerra, L., Tommasino, M., Casavola, V., and Reshkin, S. J. (2004). The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells. Breast Cancer Res. 6, R616-R628.
40. Pouyssegur, J., Dayan, F., and Mazure, N. M. (2006). Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437-443.
41. Reshkin, S. J., Bellizzi, A., Albarani, V., Guerra, L., Tommasino, M., Paradiso, A., and Casavola, V. (2000). Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na(+)/H(+) exchange, motility, and invasion induced by serum deprivation. J. Biol. Chem. 275, 5361-5369.
42. Sahai, E. (2005). Mechanisms of cancer cell invasion. Curr. Opin. Genet. Dev. 15, 87-96.
43. Scaife, R. M., Job, D., and Langdon, W. Y. (2003). Rapid microtubule-dependent induction of neurite-like extensions in NIH 3T3 fibroblasts by inhibition of ROCK and Cb1. Mol. Biol. Cell 14, 4605-4617.
44. Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M. L., Wu, L., Lindeman, G. J., and Visvader, J. E. (2006). Generation of a functional mammary gland from a single stem cell. Nature 439, 84-88.
45. Shenolikar, S., Voltz, J. W., Cunningham, R., and Weinman, E. J. (2004). Regulation of ion transport by the NHERF family of PDZ proteins. Physiology 19, 362-369.
46. Shibata, T., Chuma, M., Kokubu, A., Sakamoto, M., and Hirohashi, S. (2003). EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 38, 178-186.
47. Stemmer-Rachamimov, A. O., Wiederhold, T., Nielsen, G. P., James, M., Pinney-Michalowski, D., Roy, J. E., Cohen, W. A., Ramesh, V., and Louis, D. N. (2001). NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am. J. Pathol. 158, 57-62.
48. Sundquist, M., Thorstenson, S., Brudin, L., and Nordenskjold, B. (1999). Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group. Breast Cancer Res. Treat. 53, 1-8.
49. Tommasi, S. et al. (2005). BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy. Mutat. Res. 578, 395-405.
50. Vondriska, T. M., Pass, J. M., and Ping, P. (2004). Scaffold proteins and assembly of multiprotein signaling complexes. J. Mol. Cell Cardiol. 37, 391-397.
51. Wang, H. R., Zhang, Y., Ozdamar, B., Ogunjimi, A. A., Alexandrova, E., Thomsen, G. H., and Wrana, J. L. (2003). Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 302, 1775-1779.
52. Wang, W., Mouneimne, G., Sidani, M., Wyckoff, J., Chen, X., Makris, A., Goswami, S., Bresnick, A. R., and Condeelis, J. S. (2006a). The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J. Cell Biol. 173, 395-404.
53. Wang, Y., Chen, Y., Chen, M., and Xu, W. (2006b). AKAPs competing peptide HT31 disrupts the inhibitory effect of PKA on RhoA activity. Oncol. Rep. 16, 755-761.
54. Weigelt, B., Peterse, J. L., and van't Veer, L. J. (2005). Breast cancer metastasis: markers and models. Nat. Rev. Cancer 5, 591-602.
55. Weinman, E. J., Steplock, D., Wade, J. B., and Shenolikar, S. (2001). Ezrin binding domain-deficient NHERF attenuates cAMP-mediated inhibition of Na(+)/H(+) exchange in OK cells. Am. J. Physiol. 281, F374-F380.
56. Weinman, E. J., Wang, Y., Wang, F., Greer, C., Steplock, D., and Shenolikar, S. (2003). A C-terminal PDZ motif in NHE3 binds NHERF-1 and enhances cAMP inhibition of sodium-hydrogen exchange. Biochemistry 42, 12662-12668.
57. Wicki, A., Lehembre, F., Wick, N., Hantusch, B., Kerjaschki, D., and Christofori, G. (2006). Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9, 261-272.
58. Wittchen, E. S., Haskins, J., and Stevenson, B. R. (2003). NZO-3 expression causes global changes to actin cytoskeleton in Madin-Darby canine kidney cells: linking a tight junction protein to Rho GTPases. Mol. Biol. Cell 14, 1757-1768.
59. Wu, K. Y., Hengst, U., Cox, L. J., Macosko, E. Z., Jeromin, A., Urquhart, E. R., and Jaffrey, S. R. (2005). Local translation of RhoA regulates growth cone collapse. Nature 436, 1020-1024.
60. Yuan, X. B., Jin, M., Xu, X., Song, Y. Q., Wu, C. P., Poo, M. M., and Duan, S. (2003). Signalling and crosstalk of Rho GTPases in mediating axon guidance. Nat. Cell Biol. 5, 38-45.
61. Zhong, H., De Marzo, A. M., Laughner, E., Lim, M., Hilton, D. A., Zagzag, D., Buechler, P., Isaacs, W. B., Semenza, G. L., and Simons, J. W. (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59, 5830-5835.